Metastatic Colon Cancer
Showing 1 - 25 of >10,000
Colorectal Cancer, Metastatic Colon Cancer Trial (Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab, Placebo + FOLFIRI +
Not yet recruiting
- Colorectal Cancer
- Metastatic Colon Cancer
- Ompenaclid (RGX-202-01) + FOLFIRI + Bevacizumab
- Placebo + FOLFIRI + Bevacizumab
- (no location specified)
Aug 1, 2023
Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR
Completed
- Metastatic Colorectal Adenocarcinoma
- (no location specified)
Oct 9, 2023
Malignant Tumors of Digestive Organs, Colorectal Cancer, Colon Cancer Trial in Houston (Durvalumab, Trametinib)
Completed
- Malignant Neoplasms of Digestive Organs
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 23, 2022
Hepatocellular Carcinoma, Cholangiocarcinoma, Metastatic Colon Cancer Trial in Milan (Embolization)
Recruiting
- Hepatocellular Carcinoma
- +6 more
- Embolization
-
Milan, ItalyIRCCS Ospedale San Raffaele
Feb 3, 2023
Stage I Colon Cancer, Stage II Colon Cancer, Stage III Colon Cancer Trial in Houston (Tecentriq 1200 MG in 20 ML Injection +
Not yet recruiting
- Stage I Colon Cancer
- +2 more
- Tecentriq 1200 MG in 20 ML Injection + Capecitabine 1000 mg/m2 + Oxaliplatin 130 mg/m2
- +2 more
-
Houston, TexasBaylor College of Medicine
May 22, 2023
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma
Terminated
- Metastatic Colon Adenocarcinoma
- +27 more
- Binimetinib
- +3 more
-
San Francisco, California
- +1 more
Jan 5, 2023
Colorectal Tumors Trial in New Haven (combined TAS-102 and TAS-OX)
Completed
- Colorectal Neoplasms
- combined TAS-102 and TAS-OX
-
New Haven, ConnecticutYale Cancer Center
Jun 29, 2021
Metastatic Colon Carcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Carcinoma Trial in United States (Laboratory
Active, not recruiting
- Metastatic Colon Carcinoma
- +24 more
- Laboratory Biomarker Analysis
- +2 more
-
Corona, California
- +7 more
Oct 26, 2022
Metastatic Colon Cancer Trial in Montpellier (Blood sample)
Recruiting
- Metastatic Colon Cancer
- Blood sample
-
Montpellier, FranceICM Val d'Aurelle
Nov 3, 2021
Advanced Colon Adenocarcinoma, Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma Trial in Duarte
Active, not recruiting
- Advanced Colon Adenocarcinoma
- +24 more
- Ipilimumab
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 22, 2022
Metastatic Colon Adenocarcinoma, Metastatic Colorectal Carcinoma, Metastatic Rectal Adenocarcinoma Trial in Houston (CXCR1/2
Recruiting
- Metastatic Colon Adenocarcinoma
- +20 more
- CXCR1/2 Inhibitor SX-682
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 17, 2022
Cancer Metastatic to the Liver, Hepatocellular Carcinoma, Metastatic Melanoma Trial in United States (PV-10 (10% rose bengal
Recruiting
- Cancer Metastatic to the Liver
- +9 more
- PV-10 (10% rose bengal disodium)
-
San Diego, California
- +4 more
Mar 22, 2022
Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)
Recruiting
- Cancer of the Colon
- +4 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022
Metastatic Colon Cancer Trial in Amiens, Poitiers, Tours (Magnetic resonance imaging)
Recruiting
- Metastatic Colon Cancer
- Magnetic resonance imaging
-
Amiens, France
- +2 more
Nov 26, 2021
![](/image/sponsor/university_of_campania_"luigi_vanvitelli")
Metastatic Colon Cancer Trial in Italy (Trifluridine Tipiracil, Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX])
Completed
- Metastatic Colon Cancer
- Trifluridine Tipiracil
- Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]
-
Monserrato, CA, Italy
- +7 more
Jul 21, 2022
Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)
Recruiting
- Gastric Cancer
- +6 more
- CEA CAR-T cells
-
Nanchang, Jiangxi, ChinaThe First Affiliated Hospital of Nanchang University
Aug 23, 2023
Colonic Tumors Trial in Wuhan (neoadjuvant chemo)
Recruiting
- Colonic Neoplasms
- neoadjuvant chemotherapy
-
Wuhan, Hubei, ChinaTongji Hospital, Huazhong University of Science and Technology
Jul 19, 2022
Metastatic Colon Carcinoma, Stage IV Colon Cancer AJCC v8, Stage IVA Colon Cancer AJCC v8 Trial in New Brunswick (NBT-NM108)
Not yet recruiting
- Metastatic Colon Carcinoma
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Apr 13, 2022
Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick
Recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Oxaliplatin
- Trifluridine and Tipiracil Hydrochloride
-
Elizabeth, New Jersey
- +5 more
Oct 17, 2022
Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer Trial (CTX-009)
Not yet recruiting
- Metastatic Colorectal Cancer
- +2 more
- (no location specified)
Aug 22, 2022
Metastatic Colon Cancer Trial in Birmingham ([89Zr]Panitumumab PET-MRI)
Recruiting
- Metastatic Colon Cancer
- [89Zr]Panitumumab PET-MRI
-
Birmingham, AlabamaUAB Advanced Imaging Facility
Oct 13, 2021
Metastatic Colorectal Cancer, Chemo Effect, Peritoneal Metastases Trial in Lund, Malmö (Chemotherapy, Resection of the primary
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Chemotherapy
- +3 more
-
Lund, Skåne, Sweden
- +1 more
Mar 6, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Glioma Trial in Los Angeles (Computed
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +19 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 19, 2022
Metastatic Colon Cancer Trial in Italy, Romania, Spain (AI)
Not yet recruiting
- Metastatic Colon Cancer
- AI
-
Firenze, Italy
- +5 more
May 30, 2022